Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. senior Good
|
|
New words:
abroad, absenteeism, accrued, adding, allotted, Amsterdam, analogy, antigen, ASC, assist, auction, beneficiary, biomarker, Brexit, broaden, broader, cap, CAR, carryback, category, certiorari, cessation, chimeric, Circuit, circumstance, clarifying, closure, commentary, confidence, content, cybersecurity, declared, dissemination, distancing, downgrade, economy, eleventh, EMA, emerging, endpoint, essential, evidence, exacerbate, Exit, expiry, exploration, fact, feedback, flow, fundamental, grow, heighten, heightened, hospital, hot, hour, impede, incident, insolvency, job, judgment, Kingdom, left, London, lowest, lung, magnitude, memory, mg, minimize, movement, organizational, OS, owed, pandemic, payroll, permanently, PFS, pharmacy, physical, physically, posed, preserve, prioritization, quickly, ratably, recession, recoverable, referendum, regime, regularly, remanded, remote, remotely, residence, resource, restart, resume, rolling, running, satisfactory, Seattle, sequester, Seventy, shelter, shifted, slowdown, slower, sooner, spread, strain, supplement, supplementing, syndrome, synergistic, tariff, toxicity, travel, turn, unavailable, unexpected, unused, upheld, virtual, war, warm, worsen, worsening
Removed:
AbbVie, Abraxane, ADC, adjusted, alpha, Apexigen, ASCO, asthma, atezolizumab, Avastin, avelumab, Bavencio, Bellina, bevacizumab, Biopharma, Canada, CDI, Celgene, chronic, CNS, colony, combining, comparative, consolidated, COPD, Daiichi, Deciphera, derecognized, Diego, Division, Eisai, eliminate, enact, eribulin, examine, excise, expanded, filer, focusing, folate, footnote, Frank, gemcitabine, Genentech, Glaxo, GlaxoSmithKline, govitecan, Group, GSK, Halaven, ImmunoGen, immunologic, inhibitor, initiating, integrate, Jordan, Kimmel, kinase, Korea, lacnotuzumab, Lynparza, marginal, Matthew, McLinn, mesylate, mirvetuximab, modify, modifying, molecule, Mongiello, Navelbine, niraparib, object, obstructive, offshore, olaparib, Orphan, passing, pathway, permission, pexidartinib, Pfizer, pocket, poly, polymerase, poster, presentation, proximity, pulmonary, purpose, reagent, refractory, removed, repatriated, repealing, requirement, resolution, respiratory, Rubraca, rucaparib, sacituzumab, Sagent, Sankyo, selection, Sidney, Simplification, small, Society, soravtansine, sponsor, Stand, stimulating, Syndax, talazoparib, Tecentriq, TKI, top, topotecan, Trickett, tyrosine, UCB, unified, veliparib, vi, vinorelbine, Wendler, Xeloda, Yale, Zejula
Filing tables
Filing exhibits
Related press release
Associated FPRX transcripts
FPRX similar filings
Filing view
External links